Are pvcrt-o and pvmdr1 Gene Mutations Associated with Plasmodium vivax Chloroquine-Resistant Parasites?
(1) Background: Malaria remains a significant global public health issue. Since parasites quickly became resistant to most of the available antimalarial drugs, treatment effectiveness must be constantly monitored. In Brazil, up to 10% of cases of vivax malaria resistant to chloroquine (CQ) have been...
Saved in:
Published in | Biomedicines Vol. 12; no. 1; p. 141 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
01.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | (1) Background: Malaria remains a significant global public health issue. Since parasites quickly became resistant to most of the available antimalarial drugs, treatment effectiveness must be constantly monitored. In Brazil, up to 10% of cases of vivax malaria resistant to chloroquine (CQ) have been registered. Unlike
, there are no definitive molecular markers for the chemoresistance of
to CQ. This work aimed to investigate whether polymorphisms in the
and
genes could be used as markers for assessing its resistance to CQ. (2) Methods: A total of 130 samples from
malaria cases with no clinical and/or parasitological evidence of CQ resistance were studied through polymerase chain reaction for gene amplification followed by target DNA sequencing. (3) Results: In the
exons, the K10 insert was present in 14% of the isolates. Regarding
, T958
and F1076
haplotypes showed frequencies of 95% and 3%, respectively, while the SNP Y976
was not detected. (4) Conclusions: Since K10-
and F1076
/T958
-
polymorphisms were detected in samples from patients who responded well to CQ treatment, it can be concluded that mutations in these genes do not seem to have a potential for association with the phenotype of CQ resistance. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2227-9059 2227-9059 |
DOI: | 10.3390/biomedicines12010141 |